We chat with Sickboy podcast host Jeremie Saunders and Dr. Sanja Stanojevic, an Associate Professor in the Department of Community Health and Epidemiology at Dalhousie University, about a new report that demonstrates access to the cystic fibrosis (CF) drug Trikafta in 2021 would result in profound health improvements by 2030 for people living with cystic fibrosis who take the drug.
Health
Study forecasts new cystic fibrosis therapy could reduce deaths by 15 per cent, improve median age of survival by nine years.
More Videos
-
Experts share vital lifesaving safety tips for summer swimmers
-
Most Inspiring Immigrants: Sevtap Savas
-
New hospital in Kentville focuses on mental health and addiction support
-
New wellness facility in Halifax empowering women
-
Canadian Medical Association calls for healthcare stability
-
Calls for improved reproductive healthcare in N.S.
You are viewing an Accelerated Mobile Webpage.
View Original Article